Home>Topics>Stocks>Biomed Realty Trust

Biomed Realty Trust BMR

  1. All
  2. Commentary
  3. Stock Reports
  4. Headlines
    1. BioMed signs Bristol-Myers to more lab and office space


      Fri, 25 Jul 2014

      Bristol-Myers Squibb has signed a 10-year lease for about 61K square feet of additional lab and office space at BioMed Realty Trust 's ( BMR -0.4% ) Woodside Technology Park in Redwood City, CA. With this lease, Bristol-Myers will have 194

    2. Should You Like Citigroup Just Because Leon Cooperman Does?


      Fri, 18 Jul 2014

      By Abba's Aces : The last time I wrote about Citigroup Inc. (NYSE: C ) I stated, "I'm not going to be buying the stock right now because I feel it is just too risky but I'll continue to let what I own ride the tide." Since writing the article, the stock has increased 4.33% versus the 0.14% drop the

    3. Ehh, What's Up DOC?


      Wed, 2 Jul 2014

      Health Care REITs. The five new REITs added to MLV's equity research group consists of Aviv REIT ( AVIV ), BioMed Realty ( BMR ), LTC Properties ( LTC ), Physicians Realty ( DOC ), and Sabra Health Care ( SBRA ). MLV's coverage of these small cap

    4. MLV & Co. initiates coverage on healthcare REIT names


      Fri, 27 Jun 2014

      with $30 PT. The company is exposed to risk from higher rates due to its long-term triple-net leases. BioMed Realty Trust ( BMR ) is initiated at Hold with $23 PT, with Morgan saying the valuation reflects the near-term positives

    5. Biomed Realty Trust Inc declares $0.25 dividend


      Mon, 16 Jun 2014

      BioMed Realty Trust , Inc. ( BMR ) declares $0.25/share quarterly dividend , in line with previous. Forward yield 4.54% Payable July 15; for shareholders of record June 30; ex-div June 26. Post your comment!

    6. Dropping Coverage of BioMed Realty Trust


      Fri, 13 Jun 2014

      We are dropping coverage of BioMed Realty Trust . We cover a selection of roughly 1,500 stocks and adjust our coverage as necessary based on client demand and investor interest.

    7. Maintaining Our View on BioMed Realty Trust Following First-Quarter Results


      Thu, 1 May 2014

      A number of moving parts influenced year-over-year comparisons in life-science landlord BioMed's first-quarter results, but overall results are tracking near our expectations, and we're maintaining both our $20 fair value estimate and our no-moat rating for the firm. For the quarter, on a ...

    8. We Remain Cautious on BioMed Following Mixed 4Q Results; Maintaining $20 Fair Value Estimate


      Thu, 6 Feb 2014

      Lab and research space landlord BioMed Realty Trust reported fourth-quarter results that were near our expectations. We're maintaining both our $20 fair value estimate and no-moat

    9. New Morningstar Analyst Report for BioMed Realty Trust Inc

      Stock Reports

      Fri, 20 Dec 2013

      Many of BioMed's tenants lack proven, long-term revenue streams and are instead reliant upon investment capital for early-stage development expenses. Relative to regular office properties, life sciences real estate involves specialized infrastructure. If demand for life science space falls, it's

    10. BioMed's Per-Share Metrics Fail to Live Up to Reported Headline Growth; Maintaining $20 Fair Value


      Wed, 6 Nov 2013

      Life sciences landlord BioMed Realty Trust reported solid headline growth due largely to its recent acquisition of Wexford's portfolio, but after accounting for incremental

    « Prev12345Next »
    Content Partners